Recent Press Releases

McConnell-Sponsored Sunscreen Innovation Act Passes Senate

Two Kentucky manufacturing facilities wait on FDA for approval of sunscreen ingredients that would help protect against cancer-causing UVA rays

September 18, 2014

Washington, D.C. – U.S. Senate Republican Leader Mitch McConnell announced that the bipartisan Sunscreen Innovation Act, which would ensure sunscreen ingredients receive a timely and transparent review by the Food and Drug Administration (FDA), was approved by the United States Senate. Senator McConnell is an original co-sponsor of the bill. The House bill sponsored by Congressman Ed Whitfield (KY-01) passed earlier this year.

Skin cancer is the most common form of cancer in the country, and a known contributor to developing skin cancer is over exposure to ultraviolet (UV) radiation.  Despite this public health threat, for more than a decade the FDA has failed to review new sunscreen ingredient applications that include technologies more capable of protecting skin against harmful UVA rays.  These same technologies in pending U.S. sunscreen ingredient applications are available in Europe and other countries overseas, and in some cases have been for more than 15 years. 

Ashland Inc., a global specialty chemical company with a facility in Calvert City, manufactures precursor ingredients for these innovative sunscreens, and the cosmetics and beauty company, L’Oréal, has a finished product manufacturing facility in Florence. L’Oréal has two sunscreen ingredients pending approval, but they have been held up by the backlog at FDA.

“This legislation will not only benefit Kentucky workers that manufacture these innovative sunscreen ingredients at facilities in Calvert City and Florence, but it has the potential to provide greater protections for American families looking forward to spending some time outdoors but are worried about the harmful UVA rays,” said Senator McConnell.

“As a proud Kentucky employer and pioneer in sunscreen innovation since L'Oreal's founder invented the first sunscreen in 1936, L’Oreal USA commends Senator McConnell and his colleagues in the U.S. Senate for its bipartisan passage of the Sunscreen Innovation Act, S. 2141.  L’Oreal USA has always been committed to giving American consumers access to a broad range of products to meet their sun protection needs, and the passage of this legislation puts American consumers one step closer to the latest sunscreen technology,” said Kristina Schake, Chief Communications Officer of L’Oreal USA.

"Ashland appreciates the prompt response and strong support provided by Senator McConnell for this important legislation,” said John Riley, Ashland director of government relations.

McConnell: ‘We Stand with the Ukrainian People’

‘So we stand with the Ukrainian people in their struggle against external aggression. And we stand with them in their struggle to secure the same kinds of rights and liberties each of us enjoy here.’

September 18, 2014

WASHINGTON, D.C.U.S. Senate Republican Leader Mitch McConnell made the following remarks on the Senate Floor supporting Ukrainian autonomy:

“Earlier this morning, we had an opportunity to hear from Ukraine’s President, Petro Poroshenko.

“Ukraine is a friend of the United States, and it has looked to the West to meet naked Russian aggression. As President Poroshenko’s speech reminded us, there are many shared objectives that bind our countries: like the pursuit of freedom, and representative government. So we stand with the Ukrainian people in their struggle against external aggression. And we stand with them in their struggle to secure the same kinds of rights and liberties each of us enjoy here.”

McConnell Voices Support for Training Syrian Opposition, Ebola Containment Measures

‘In summary this isn’t perfect legislation, but it begins to address many of our constituents’ top concerns without raising discretionary spending. And it positions us for better solutions in the months to come.’

September 18, 2014

WASHINGTON, D.C.U.S. Senate Republican Leader Mitch McConnell made the following remarks on the Senate Floor regarding his support for equipping and training Syrian opposition and for containing Ebola:

“Today, the Senate will consider House-passed legislation to fund the government and address the twin threats of Ebola and ISIL. These are important issues. I know many members on both sides plan to support this legislation. I know that others have concerns too.

“I understand those concerns. I share some of them. But while no bill is perfect, I believe this is legislation worth supporting.

“I’d like to thank my fellow Kentuckian, Representative Hal Rogers, for his leadership and his work on this bill. Because it does a lot of important things, and all without raising discretionary spending.

“It would reauthorize important counter-narcotic operations that help keep our children and communities safe.

“It would extend the Internet Tax Freedom Act until December, giving us a chance to secure a permanent extension.

“It would block some of the Administration’s discriminatory policies against Kentucky coal.

“And it would help address the Administration’s veterans’ crisis by providing more resources to address the claims backlog and investigations into potential wrongdoing. That’s a positive step toward the more comprehensive reforms Republicans would like to see.

“Critically, the legislation would provide authorization to train and equip a moderate Syrian opposition ground force—a key component of the President’s efforts to disrupt, dismantle, and defeat ISIL. While I’m concerned about the ability of the coalition to generate sufficient combat power to defeat ISIL within Syria, I support the President’s proposal to begin this program. The authorization is of limited duration, and it now contains some important reporting requirements that will allow Congress to assess and oversee this program to measure whether the mission is being accomplished.

“The Ebola crisis is another area where the President deserves Congress’ support. As you know, he recently announced several measures to contain the spread of the disease in Africa and prevent it from reaching our shores. Accordingly, the bill contains additional resources to support research and bolster our nation’s efforts in assisting Africa to manage this growing crisis.

“In summary this isn’t perfect legislation, but it begins to address many of our constituents’ top concerns without raising discretionary spending. And it positions us for better solutions in the months to come.”